HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Cortexyme (CRTX) for Possible Securities Law Violations, Encourages Investors with Significant Losses to Contact Firm’s Attorneys
April 26, 2022 19:07 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 26, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Cortexyme, Inc. (NASDAQ: CRTX) investors who suffered significant losses to submit your losses now. The firm is investigating...
CIR INVESTIGATION: Hagens Berman, National Trial Attorneys, Investigating Cortexyme (CRTX) for Possible Securities Law Violations, Encourages Investors with Significant Losses to Contact Firm
April 20, 2022 14:04 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 20, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Cortexyme, Inc. (NASDAQ: CRTX) investors who suffered significant losses to submit your losses now. The firm is investigating...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm
April 13, 2022 12:43 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 13, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Cortexyme, Inc. (NASDAQ: CRTX) investors who suffered significant losses to submit your losses now. The firm is investigating...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm
April 07, 2022 10:28 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 07, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Cortexyme, Inc. (NASDAQ: CRTX) investors who suffered significant losses to submit your losses now. The firm is investigating...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm
March 28, 2022 10:33 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 28, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Cortexyme, Inc. (NASDAQ: CRTX) investors who suffered significant losses to submit your losses now. The firm is investigating...
CRTX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm
March 19, 2022 10:05 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 19, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Cortexyme, Inc. (NASDAQ: CRTX) investors who suffered significant losses to submit your losses now. The firm is investigating...